{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -41.3, "sharesOutstanding": 54961700, "bookValue": 72.296, "fiftyDayAverage": 112.64, "fiftyDayAverageChange": -7.6399994, "fiftyDayAverageChangePercent": -0.0678267, "twoHundredDayAverage": 139.27, "twoHundredDayAverageChange": -34.270004, "twoHundredDayAverageChangePercent": -0.2460688, "marketCap": 5770978304, "priceToBook": 1.4523625, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "currency": "JPY", "financialCurrency": "JPY", "regularMarketOpen": 106.0, "averageDailyVolume3Month": 297422, "averageDailyVolume10Day": 242010, "fiftyTwoWeekLowChange": 3.0, "fiftyTwoWeekLowChangePercent": 0.029411765, "fiftyTwoWeekRange": "102.0 - 322.0", "fiftyTwoWeekHighChange": -217.0, "fiftyTwoWeekHighChangePercent": -0.67391306, "fiftyTwoWeekLow": 102.0, "fiftyTwoWeekHigh": 322.0, "earningsTimestamp": 1683889140, "earningsTimestampStart": 1691647200, "earningsTimestampEnd": 1691992800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1480982400000, "priceHint": 2, "marketState": "CLOSED", "regularMarketChange": -3.0, "regularMarketTime": 1683872102, "regularMarketDayHigh": 107.0, "regularMarketDayRange": "105.0 - 107.0", "regularMarketDayLow": 105.0, "regularMarketVolume": 148800, "regularMarketPreviousClose": 108.0, "bid": 105.0, "ask": 106.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "regularMarketChangePercent": -2.777778, "regularMarketPrice": 105.0, "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "exchange": "JPX", "shortName": "KUBOTA PHARMACEUTICAL HLDGS CO ", "longName": "Kubota Pharmaceutical Holdings Co., Ltd.", "messageBoardId": "finmb_26745995", "market": "jp_market", "symbol": "4596.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Kasumigaseki Tokyu Building", "address2": "4th Floor 3-7-1 Kasumigaseki Chiyoda-ku", "city": "Tokyo", "zip": "100-0013", "country": "Japan", "phone": "81 3 6550 8928", "fax": "81 3 6550 8929", "website": "https://www.kubotaholdings.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ryo  Kubota", "age": 56, "title": "Founder, Chairman, Chief Exec. Officer, Pres and Representative Exec. Officer", "yearBorn": 1966, "fiscalYear": 2018, "totalPay": {"raw": 84604000, "fmt": "84.6M", "longFmt": "84,604,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Tomomi  Sukagawa", "title": "Director of Investor Relations & Communication", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1546214400, "maxAge": 86400}}], "error": null}}